A FTER the isolation, determination of structure,1-5 and synthesis6 of serotonin (5-hydroxytryptamine), Erspamer and Asero7 found that the substance producing the fluorescence and staining properties of the chromaffin cells of the intestinal tract was identical with serotonin. Serotonin is formed by enzymatic hydroxylation and decarboxylation of the amino acid, tryptophan, and is degraded in part to 5-hydroxyindoleacetic acid, which is excreted into the urine. 8 Malignant gastrointestinal carcinoid tumors, which are believed to be derived from chromaffin cells, may produce excessive amounts of serotonin.9 When enough functioning tumor tissue is present, usually because of hepatic metastases, a syndrome ensues consisting of diarrhea, right-sided valvular heart disease, cyanosis, and an unusual flushing of the skin.10-13 Increased amounts of serotonin are found in the blood of these patients"4 and large amounts of 5-hydroxyindoleacetic acid may appear in the urine,'5 iindicating that this is an endocrine tumor, as was suspected in 1914 by Masson.16 The pathogenesis of the cutaneous vascular changes has not been established although they have been attributed to the direct pharmacologic effect of excessive amounts of circulating serotonin liberated from the tumor. The endocardial sclerotic lesions have been ascribed to a
From the Research Division of The Cleveland Clinic Foundation and The Frank E. Bunts Educational Institute, Cleveland, Ohio. 523 direct action of serotonin ;12 destruction in the lungs of serotonin released from liver metastases might account for the failure to find lesions in the left heart. Since elevation of the pulmonary artery pressure may follow the injection of serotonin into dogs'7 or normotensive and hypertensive patients,'8 Thorson'9 suggested that the profound hemodyniamic changes associated with attacks of flushing might place an increased strain on the right heart and could be a basis for the development of valvular lesions.
A serotonin antagonist, 1-benzyl-2,5-dimethyl serotonin hydrochloride, abbreviated BAS, a benzyl analog of serotonin ( fig. 1 ) was synthesized by Woolley and Shaw.20' 21 Orally administered in doses of 1 mg. per Kg., it protected dogs from the pressor action of intravenous serotonin. 22 Another serotonin antimetabolite, 2-brorno-d-lysergic acid diethylamide, hereinafter called bromo-LSD (coded as BOL 148) ( fig. 1 ), was highly effective in blocking the action of serotonin on isolated uterine and intestinal strips;23" 24 inhibition of the effects of serotonin on arterial pressure and renal function was also shown in vivo in the intact anesthetized rat.25 A third substance, chlorpromazine hydrochloride, bears no structural resemblance to serotonin, but it has also been shown to antagonize the effects of serotonin in in 5 normal subjects and in 2 patients with malignant carcinoid tumors of the intestinal tract. Neither of the latter patients had clinical evidence of associated endocardial or valvular heart lesions. Both, however, had frequent attacks of flushing. These enabled us to study (1) the nature of this flushing, (2) the influence thereon of 3 serotonin antagonists, BAS, bromo-LSD, and chlorpromazine, and (3) the effects of these antagonists on the vascular action of endogenous and exogenous serotonin, as well as (4) other systemic and subjective effects of these agents. April 15, 1956 . Cutaneous changes consisted in persistent cyanosis of the face and paroxysmal attacks of intense purple-red flushing of the face, neck, and extremities. With the latter there were often associated sensations of local heat in the face and generalized tingling of the skin. Palpitation, tachycardia, breathlessness, and sweating were common during the attacks. Episodes of flushing lasted 2 to 3 minutes, occurred spontaneously 10 to 20 times a day, and were often accompanied by abdominal cramps and nausea. Flushes could also be provoked by emotional stress, physical exertion, or evacuation of the bowels, and were aggravated by standing.
METHODS
The pulse was 80 and the blood pressure 112/72 mm. Hg lying and 100/70 mm. Hg standing. The sclerae were slightly icteric; and optic fundi were normal. The heart was not enlarged, rhythm was regular, and there was a soft murmur at the apex.
No clubbing of the digits was seen; peripheral arterial pulsations were normal. The liver was firm, nodular, nontender, and palpable 6 cm. below the costal margin.
Roentgenograms showed the heart to be normal in size and configuration; cardiac pulsation appeared normal during fluoroscopy. An electrocardiogram showed sinus rhythm, slight elevation of the S-T segment in leads I, II, aVL, V2-6, and slight depression in Lead aVR.
Hemoglobin was 16 Gm. per cent; hematocrit, 58 ml.; red blood count, 6.48 million per mm.3 with occasional target cells; white blood count, 8,800 per mm. ;3 the differential count was normal. The platelet count, bleeding time, coagulation time, clot retraction, prothrombin time, sedimentation rate, icterus index, thymol turbidity, fasting blood sugar, blood urea, and plasma creatinine were normal. The electrophoretic pattern of the serum proteins and the ultracentrifuge lipoprotein pattern were also normal.
The total blood histamine was 11 jug. per cent, which is only slightly higher than usual values (4 to 7 gg. per cent).* The urine histamine was 27 In case 1, in contrast with the effect of epinephrine, the intravenous injection of 10 ,g. of norepinephrine produced an intense flush, identical with that of spontaneous attacks; the flush appeared during the depressor phase of 10 to 20 mm. Hg that followed the initial abrupt rise in pressure ( fig. 3 ). Repetitive injection of norepinephrine induced generalized flushing that subsided usually before the blood pressure returned from its depressed to control levels. In mg. of serotonin creatinine sulfate was followed by a marked pressor response and an intense flush. Repeated doses of TEAC were then injected intravenously for a total dosage of 10 mg. per Kg.; after each injection a mild flush appeared with every fall in arterial pressure. After TEAC, the pressor response to norepinephrine was slightly enhanced and the pressor response to serotonin reduced, but the flushes induced by these drugs or by nitroprusside were neither prevented nor intensified.
Effect of Serotonin Antagonists
Oral Administration of BAS. BAS was given to case 1 by mouth in gradually increasing doses of 100 to 400 mg. (1.8 to 7.5 mg. per Kg.) for 9 days. The drug had no effect on blood pressure and pulse rate, and the number of flushes was the same. The patient thought, however, that their severity was slightly diminished. The daily urinary excretion of 5-hydroxyindoleacetic acid was not affected.
Oral Administration of Bromo-LSD. Bromo-LSD was given to case 2 by mouth in increasing doses up to 20 mg. daily for 7 days. The patient noted mild nasal congestion and thought that the flushes were less intense, but these did not change in appearance nor in rate of recurrence. The range of daily urine excretion of 5-hydroxyindoleacetic acid was unaltered.
Oral Administration of Chlorpromazine. Chlorpromazine was given to case 2 by mouth in daily doses of 100 mg. for 9 months. The patient meticulously kept a daily record of the number and intensity of flushing attacks for 3 months before and during the taking of the drug. The number of flushes did not decrease, and actually became more frequent; however, the intensity and duration of flushing attacks significantly lessened. This was accompanied by a decrease in the severity of the diarrhea and in the frequency of episodes of vomiting and abdominal pain. There was no significant change in average daily urinary excretion of 5-hydroxyindoleacetic acid.
Effects of Intravenously Administered Bromo-LSD Psychic Effects. In man small doses of bromo-LSD are said to produce none of the bizarre psychic effects noted with lysergic acid diethylamide231 31 but this is not the case when bromo-LSD is administered intravenously in large doses. Thus, when constant intravenous infusions of bromo-LSD were given to 2 normal subjects (cases 5 and 6) both experienced psychic changes, which became more severe as the infusion continued and persisted for 3 to 4 hours after the infusion was stopped. No hallucinations were noted but there were feelings initially of drowsiness, depression, anxiety and apprehension, followed by feelings of irritation, restlessness, and tenseness, and later, intensely disagreeable sensations of unreality and depersonalization, inexplicable feelings of strangeness and mild confusion. On a subsequent day, both these subjects and another normal subject (case 7) received constant intravenous infusions of serotonin, followed in 10 to 44 minutes by a simultaneous infusion of bromo-LSD. Psychic changes were also experienced during the simultaneous infusions of serotonin and bromo-LSD, although the mental disturbances seemed somewhat less intense than when bromo-LSD was given alone. Furthermore, all other sub- An intravenous infusion of bromo-ISD (1 mg. per minute) was started and determinations were repeated after 10 minutes of infusion. Bromo-LSD had no effect on pulmonary artery pressures. The systemic mean pressure was un- There was no significant difference between serum serotonin levels in hepatic venous blood, mixed venous blood, and peripheral arterial blood, and no appreciable changes in these concentrations during the infusion of bromo-LSD.
Influence on Vascular Action of Norepinephrine (table 2) . Injections of norepinephrine prior to infusion of bromo-LSD were followed in all subjects, both careinoid (cases 1 and 2) and normal (cases 3, 4, and 5), by swift rises of arterial pressure of from 20 to 56 mm. Hg systolic and 3 to 32 mm. Hg diastolic. In both carcinoid patients norepinephrine provoked flushing of the face and neck, which appeared as the pressure fell to or below the control level. Arterial pressure did not change appreciably during the intravenous infusion of bromo-l.SD nor did the pressor responses to norepinephrine; flushing of the skin occurred in case 1 but not in case 2.
Influence on Vascular Action of Serotonin (table 3) . Prior to the infusion of bromo-LSD, single intravenous injections of serotonin in both control and carcinoid subjects were followed by flushes of the skin similar to spontaneous attacks occurring in the carcinoid patient and by pressor responses of 29 to 58 mm. Hg systolic and 9 to 57 mm. Hg diastolic (table 3) . The flush, involving the face, neck, and extremities, was intense in 4 patients and mild in 1 (case 5). Subjective discomfort was profound in all subjects and characterized by nausea, Single injections of serotonin during the infusion of bromo-LSD failed to provoke flushing in cases 2 and 3, the flush was less intense and diffuse in cases 1 and 4, but actually seemed more marked in 1 control subject (case 5). The pressor response in all subjects was similar to that observed when serotonin had been injected alone. The other effects of serotonin were usually milder and less uncomfortable for most subjects, but 1 control subject (case 5) found that the subjective discomfort due to serotonin was intensified during the infusion of bromo-LSD.
DIscussIoN
Demonstration of large quantities of serotonin in carcinoid tumor extracts,9 hyperserotonemia,13' 14 and increased urinary excretion of serotonin end-products'5 in carcinoid patients, all implicate serotonin in the pathogenesis of the vasomotor episodes. This assumption is supported by precipitation of flushes in some patients by palpation of the tumor.'3 32 33 Flushing was said not to occur as a result of intravenous injections of serotonin in man ; [34] [35] [36] intravenous infusions of 0.8 to 1.2 mg. per minute of serotonin creatinine sulfate produced tingling and burning of the face but no flush was seen.'5 However, in the present study, rapid single intravenous injections of larger (1.8 to 4.0 mg.) doses of serotonin provoked mild to moderate, at times intense, flushes in normal as well as carcinoid subjects. This was also observed in hypertensive patients.37 The flushes appeared to be similar in every way to the paroxysmal attacks in carcinoid patients.
Hypotension and syncope accompanied by flushing was observed in several carcinoid patients.13 33, 38 One of our carcinoid patients (case 1) had, at rest, a low systemic resistance, and lowering of his arterial pressure by several different agents was invariably followed by attacks of flushing. This suggests that hypotension either directly or by vasomotor reflexes stimulates the tumor to release increased amounts of serotonin into the blood. Either assumption presupposes that the tumor is innervated.
The to 20 ng. daily also failed to relieve flush and diarrhea in case 2; smaller oral doses of bromo-LSD (1 to 15 mg. a day) did not antagonize the circulatory effects of serotonin in other carcinoid subjects.38 40, 41 The dosages of these antimetabolites may be inadequate but they were larger than those used before and increased doses did not seem practicable.
Intravenous infusion of bromo-LSD in large doses (0.5 to 5.0 mg. per minute) did not effectively block the pressor response to serotonin. Serotonin-induced flush and other pharmacologic effects of serotonin were diminished or failed to appear in some subjects during infusion of bromo-LSD but this was not a consistent observation; in 1 normal subject (case 5) there was an aggravation of all reactions to serotonin. In normal rats, bromo-LSD (2.5 Gm. per Kg. intravenously) inhibited the effects of subse-(uent injections of serotonin on arterial pressure and renal function,25 but had little effect when given during serotonin infusion, an observation consistent with the failure of this agent to influence the course of the carcinoid syndrome.
Chlorpromazine was reported to alleviate the diarrhea of a patient with malignant carcinoid.12 In our experience, administration of chlorpromazine to a carcinoid patient (case 2) decreased the intensity of flushing attacks and the severity of abdominal symptoms, but had no effect on 5-hydroxyindoleacetic acid excretion.
Lysergic acid diethylamide, a potent serotonin antagonist43 induces in man temporary mental aberrations accompanied by hallucinations. 44 Bromo-LSD, when intravenously administered, did not effectively block, although it may have diminished, the vascular and other pharmacologic effects of intravenously injected serotonin. Bromo-LSD did not cause hallucinations, but in large intravenous doses produced psychic disturbances that otherwise resemble those regularly observed after small doses of lysergic acid diethylamide. These psychic effects of bromo-LSD might be due to inhibition of some central nervous action of serotonin but they were not prevented by the hyperserotonemia present in carcinoid patients and were not alleviated by infusions of serotonin in normal subjects, as was to be expected by the failure of serotonin to pass the bloodbrain barrier. Bromo-LSD in administration intravenose non blocava efficacemente (ben que illo possibilemente reduceva) le effectos vascular e alteremente pharmacologic de serotonina in injectiones intravenose. Bromo-LSD non (ausava hallucinationes, sed post le administration de grande doses intravenose illo produceva distributiones psychic que resimilava le effectos regularmente observata post parve doses de diethylamido de acido lysergic. I1 es possibile que este effectos psychic de bromo-LSD resulta del inhibition del un o del altere action de serotonina in le systema nervose central, sed illos non esseva prevenite per le hyperserotoninemia que es presente in patientes carcinoide, e illos non esseva alleviate per infusiones de serotonina in subjectos normal, como on haberea expectate lo, viste le facto que serotonina non transpassa le barriera sanguino-cerebral.
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